Recent developments
Computational Ki-67 Quantification: Where Image Analysis Helps and Where It Doesn'tComputational Ki-67 quantification: where image analysis helps and where it doesn't: what the technology does, the evidence behind it, and where it stands.Reading the Regulatory Map: How FDA Clears AI in Pathology, and Why So Few Make It ThroughFDA regulatory frameworks for AI/ML Software as a Medical Device in pathology: what the technology does, the evidence behind it, and where it stands. EvideMultimodal AI Enters Prostate Prognosis: Inside the First FDA-Cleared ToolsFDA-cleared multimodal AI prognostic tools in localized prostate cancer: what the technology does, the evidence behind it, and where it stands. Evidence-baAI as First Reader: Pre-Screening Prostate and Breast BiopsiesAI-assisted cancer detection as a screening/pre-screen layer in prostate and breast biopsies: what the technology does, the evidence behind it, and where iScoring HER2 by Algorithm: Computational Analysis and the Ultralow ProblemComputational HER2 image analysis and the HER2-low/ultralow reproducibility problem: what the technology does, the evidence behind it, and where it stands.